A new drug to prevent the early stages of Alzheimer's disease could enter clinical trials in a few years' time according to scientists. Alzheimer's is the most common type of dementia, which currently affects 820,000 people in the UK, with numbers expected to more than double by 2050. One in three people over 65 will die with dementia.